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Abstract  
Aim: Determine the presence of mesenchymal stem cells (MSCs) in healthy periodontal 
tissue and periodontal granulation tissue (GT) and explore associations between immuno-
regulatory molecules and select subgingival microorganisms.  
Methods: Mesenchymal stem cells were isolated, propagated and characterised by flow 
cytometry from a region of healthy gingival tissue and inflamed GT of 10 systemically 
healthy non-smokers with chronic periodontitis. Tissue levels of immunoregulatory 
molecules were determined by qPCR and Gingival Crevicular Fluid (GCF) levels by ELISA. 
Subgingival plaque levels of periodontal pathogens were determined by qPCR  
Results: Cells with MSC-properties were isolated from both inflamed GT and healthy 
gingival (G) tissue. A pro-inflammatory process predominated in GT which was partly 
reflected in GCF and putative periodontal pathogens were higher at diseased sites. However, 
there was no significant difference in surface levels of mesenchymal (CD90, CD73, CD146, 
CD271, STRO-1), endothelial (CD105, CD106), hematopoietic (CD34, CD45) and 
embryonic (SSEA-4) stem cell markers between MSCs isolated from GT and G tissue.  
Discussion: Periodontal lesions, albeit inflamed, retain healing potential as inferred by the 
presence of MSC-like cells with similar immunophenotypic characteristics to those found in 
healthy periodontal tissue. Therefore, there might be merits for healing in preserving 
sufficient GT in-situ during periodontal surgery.  
  
Introduction  
In periodontal surgery, the excision of granulation tissue (GT) at intra-bony defects is aimed 
at improving wound healing and promoting new attachment.1-2 However, gingival curettage 
and GT removal did not improve periodontal clinical indices more than did scaling and root-
planing alone.3 In line with this finding, flap surgery in conjunction with GT excision was not 
a critical measure for promoting healing of periodontal tissues.4 Granulation tissue formation 
seems to be a hallmark of the pathogenesis of periodontal disease. Cells residing in GT 
release numerous mediators, which modulate the processes of osteoclastogenesis and 
osteoblastogenesis, including pro-inflammatory cytokines and anti-inflammatory mediators.5 
Mesenchymal stem cells are multipotent cells that can replicate as undifferentiated cells and 
have the potential to differentiate into several lineages of the mesenchymal tissue.6 Stem cells 
(SCs) expressing embryonic markers have been isolated from GT removed mainly from 
infrabony defects of four systemically healthy non-smokers, implying that these cells may 
contribute to periodontal healing once the infection is controlled.7 However, the role of SCs 
in gingival tissue homeostasis and/or pathologies remains unclear. Multipotent stromal SCs 
were isolated from human periodontal GT and these cells improved osseous repair in critical 
size defects in mice.8 Mesenchymal SC (MSC)-like populations have been found within 
inflamed gingival tissue to be functionally equivalent to MSCs derived from healthy gingival 
tissue9 and gingival-derived MSCs have been shown to exhibit immune-modulatory and anti-
inflammatory activity.10-11 Taken all together, it is speculated that MSC populations within 
infected GT promotes healing whilst dampening inflammation. Human MSCs were isolated 
from palatal connective tissue and periodontal GT to comparatively evaluate their 
properties.12 Despite their differences in colony-forming unit fibroblasts (CFU-Fs), 
population doubling times, migration potential and level of surface marker expression, MSCs 
from both sources were relatively uniform in their ultrastructure and successfully 
differentiated into osteogenic, adipogenic, and chondrogenic lineages.  
However, comparative studies on the characteristics of MSC populations derived from 
matched samples of healthy vs. diseased periodontal tissues of the same individuals, as well 
as correlations with the inflammatory “micromilieu” of residual periodontal pockets are 
systematically lacking. The aim of this study was to determine the presence and properties of 
cell populations with MSC characteristics in the GT of periodontal lesions compared to those 
isolated from healthy gingival tissue of the same individuals and determine whether ongoing 
bacterial driven inflammation alters their basic immunophenotypic profiles.  
Materials and methods 
Study cohort and clinical interventions 
Fifteen systemically healthy non-smokers with chronic periodontitis who were scheduled to 
receive periodontal surgery were recruited at the Department of Preventive Dentistry, 
Periodontology and Implant Biology (PDP&IB), Aristotle University of Thessaloniki 
(AUTh), Greece. The study was approved by the School’s Ethical Committee (22/11-01-
2016) and all participants provided informed consent.  
Inclusion criteria: periodontal pockets of probing pocket depth (PPD) and clinical attachment 
levels (CAL) >5mm with bleeding on probing (BOP) and radiographic evidence of advanced 
bone loss. Exclusion criteria: >65 years of age, history of systemic disease, compromised 
medical conditions requiring prophylactic antibiotic coverage, antibiotic therapy within the 
last three months, bisphosphonate medication, bone metabolic diseases or disorders that 
compromise wound healing, use of anti-inflammatory drugs, radiation or immunosuppressive 
therapy, narrow zone/absence of attached gingiva, pregnancy/lactation, smoking, previous 
periodontal surgery. 
Patients were screened for eligibility by a single calibrated examiner (DAA), who also 
performed the clinical (PPD, CAL, BOP, Plaque Index) and radiographic assessment. 
Eligible subjects underwent cause-related periodontal treatment which comprised strict 
plaque control measures (re-iterated over the study period) and full-mouth hand/power-driven 
instrumentation under local anaesthesia. At 6-months, the subjects were scheduled to undergo 
periodontal surgery.13 Prior to anaesthesia, GCF and subgingival plaque samples were 
collected from a diseased and a clinically healthy (PPD ≤3mm, absence of BOP, no 
radiographic evidence of bone loss) site in each individual. The designated sites were gently 
air dried and isolated from saliva by placing cotton rolls and using a saliva ejector. 
Supragingival plaque was carefully removed and GCF samples were obtained by using paper 
strips (Periopaper, OraFlow Inc., Smithtown, NY, USA). The strips were placed in the 
periodontal pocket/sulcus until mild resistance was felt and were left in-situ for 30s, taking 
care to avoid mechanical trauma. Subsequently, subgingival plaque was collected by 
inserting two sterile paper points (ROEKO ISO-40, Coltène-Whaledent GmbH, Co. KG, 
Germany) in each site for 30s. They were then stored in Eppendorf tubes (Eppendorf, 
Hamburg, Germany) at -80oC until further processed. Granulation tissue was surgically 
harvested from the denoted sites that were preferably in the same quadrant and non-adjacent. 
An internal bevel combined with an intra-sulcural incision demarcated a collar of soft tissues 
and following flap elevation, GT was sharply excised from the apical part of the pocket; 50% 
of the tissue was used for cytokine analysis and the remaining 50% for isolation/expansion of 
MSCs. A thin zone of the soft tissues lining the designated healthy sulcus was also harvested 
and was processed in a similar manner to the GT biopsy.  
MSCs culture and characterisation 
The GT biopsy designated for MSC culture (GT-MSCs) and the analogous disease-free 
specimen (G-MSCs) were enzymatically digested as described previously,14 seeded in 25cm2 
flasks, expanded at 37oC in 5% CO2 in α-MEM (alpha-Minimum Essential Medium, Life 
Technologies, Thermo Fisher Scientific, Paisley, UK) supplemented with 15% FBS (Life 
Technologies), 100 units/ml of penicillin, 100 mg/ml of streptomycin and 0.25 mg/ml of 
Amphotericin-B (all from Life Technologies). GT-MSCs and G-MSCs were characterised by 
mesenchymal (CD90, CD73, CD146, CD271, STRO-1), endothelial (CD105, CD106), 
hematopoietic (CD34, CD45) and embryonic (SSEA-4) SC-markers at passage-2 by flow 
cytometry, using a Guava® easyCyte-8HT Benchtop Flow Cytometer (Merck Millipore, 
Billerica, Massachusetts, U.S.A).14 A total of 50,000 events were acquired per sample. Data 
were analysed using GuavaSoft-3.1.1 and Summit-5.1 software.  
Gene expression in tissue  
The section of the biopsy sample was placed into RNA-later (Sigma–Aldrich, Dorset, UK), 
immediately after collection and stored at -20ºC until required. Tissue was cut into 1.0mm 
pieces and transferred into buffer-RLT (Qiagen, Crawley, UK) and homogenised for 1min 
with a disposable pestle. RNA was extracted from tissue using the RNeasy® mini kit for 
fibrous tissue (Qiagen, UK), the yield was assessed spectrophotometrically and 1.0µg of 
RNA was converted to cDNA using the SuperScriptTM First-Strand Synthesis Kit (Life 
Technologies) according to the manufacturers’ instructions. Real-time PCR analysis of the 
expression of IL-1β, IL-6, IL10, TNF-α, IL-17A, IL-17E, TGF-β and two reference genes, 
GAPDH and RNA polymerase-II, was performed using TaqMan assay on demand assays 
(ABI/Life Technologies). The PCR efficiency was determined using a previously described 
method15 and all primer-probe sets exhibited efficiencies of 0.90-1.05. For each gene, the 
level of expression was adjusted by the geometric mean of the two-reference gene critical 
threshold-values.  
Cytokine levels in GCF 
Enzyme-linked immunosorbent assay and specific kits for IL-1β, IL-6, IL-10, TNF-α, IL-
17A, IL-17E (Pepro Tech, London UK), TGF-β (Mabtech AB, Stockholm Sweden) were 
used for cytokines measurement in GCF. Minimum detection limits were: IL-1β, IL-6, IL-10, 
TNFα and IL-17A, all 1.9pg/ml; IL-17E and TGF-β, both 3.9pg/ml. 
Quantities of subgingival plaque microorganisms  
The Epicentre Masterpure Gram-positive DNA isolation kit (Cambio, Cambridge, UK) was 
used to prepare genomic DNA from the plaque samples and from known quantities of 
laboratory strains of the target microorganisms. The amount and purity of DNA was checked 
spectroscopically. Real-Time-PCR analysis was used to determine copy numbers of P. 
gingivalis,16 A. actinomycetemcomitans, F. nucleatum, T. forsythia,17 T. denticola18 and 
Streptococcus mitis19 in subgingival plaque. Known numbers of the target microbes were 
used to create standard curves from which copy numbers of unknown samples were 
determined.  
Statistical analyses  
Statistical power calculation was based on the assumptions that the data were dependent and 
either normally distributed or log-normally distributed. For an effect size of 1, utilising the 
paired t-test the estimated minimum number per group required to exceed 80% statistical 
power (α=0.05) were n=10. Q-Q plot analysis for each parameter determined that data were 
not normally distributed. To facilitate non-parametric analyses and multiple comparisons in 
cytokines/bacteria and to allow for covariates the sample size was increased to n=15. All 30 
GCF and plaque samples were analysed for cytokine measurements and quantification of 
select bacteria, respectively, 30 tissue specimens were analysed for cytokine gene expression 
but MSCs could only be isolated/expanded from 20 specimens (NGT=Ndisease-free=10), 
resulting in samples not being perfect pairs. Analysis of this data set was performed using 
1000 random data combinations in a Permutation test based on the Wilcoxon test20 using R-
Project for Statistical Computing. Otherwise the paired data sets (GT and disease-free tissues) 
were analysed using SPSS Inc. version 21 (IBM, Chicago, USA and Graphpad Prism V5, La 
Jolla, USA). Correlation between the biochemical and microbial parameters were evaluated 
with the Kendal Tau test. Biological specimens and clinical data were coded, so that the 
laboratory analysis was blind to the clinical details.   
Results  
Clinical data  
All periodontal defects (N=15) were located in posterior segments. Demographic details of 
the participants and clinical data are shown in Table 1.  
MSC cultures  
Few morphological differences were observed between GT-MSC and G-MSC cultures. Both 
types of cells presented a typical fibroblast-like, spindle-shaped morphology. Phenotypic 
characterisation indicated similar profiles for GT-MSCs and G-MSCs, characterised by high 
expression (>95%) of CD73 and CD90 and low expression (<1-2%) of STRO-1, CD45, 
CD34 and CD271 in both GT-MSCs and G-MSCs (N=10) (Fig. 1). However, a high inter-
subject variability was noted in the expression of CD105, CD146, CD106, CD73, CD90 and 
SSEA-4 with no significant differences between GT-MSCs and G-MSCs (all p>0.5; Fig. 2).  
Cytokine and bacterial profiles 
The expression of several pro-inflammatory cytokines was significantly higher in GT 
compared with the disease-free biopsy tissue (IL-1β: p=0.007; TNF-α: p=0.0001; IL-6: 
p=0.011; IL-17A: p=0.0001; Fig. 3A-B-C-E, respectively). Despite the observation that 
median levels were higher for IL-10-, IL-17E-, or TGF-β mRNAs inside GT, this failed to 
reach statistical significance (all p>0.1; Fig. 3D-F-H). There was a significantly higher ratio 
of IL-17A:IL-17E mRNA in the GT compared with the disease-free tissue specimens 
(p=0.001; Fig. 3G). 
The amounts of TNF-α were significantly higher in GCF sampled from the GT-associated 
site than the disease-free site (p<0.039; Fig. 4B). Amounts of IL-17E were significantly lower 
in the GCF samples from the diseased sites, in parallel with a significantly higher IL-17A:IL-
17E ratio (p<0.0054, p=0.008, respectively; Fig. 4F-G). In contrast, there was no significant 
difference in the amounts of the other cytokines measured in the GCF of diseased sites versus 
disease-free sites (p>0.10; Fig. 4A-C-D-E-H).  
The median copy numbers of P. gingivalis (p=0.021), F. nucleatum (p=0.003), T. denticola 
(p=0.035), and T. forsythia (p=0.0052) were significantly higher in the GT-associated plaque 
samples compared to the disease-free samples (Fig. 5A-B-C-D, respectively). In contrast, the 
median copy numbers of A. actinomycetemcomitans and S. mitis tended to be lower in the GT 
samples but failed to reach statistical significance (both p>0.1; Fig. 5E-F). 
Correlation analyses  
Significant correlations were observed between cytokines in GCF and the CD markers on 
MSCs isolated from GT (Table 2). For instance, IL-6 correlated positively with CD105 
(Tau=0.556, p=0.025) and IL-17E with CD106 (Tau=0.600, p=0.016) and IL-17A with 
CD146 (Tau=0.511, p=0.04). There were also statistically significant correlations between 
gene transcript levels in the GT and CD markers; IL-17E mRNA correlated positively with 
CD105 (Tau =0.667, p=0.012) and the IL-17A:IL-17E transcript ratio negatively with CD105 
(Tau=-0.556, p=0.037).  
The bacteria F. nucleatum and T. denticola, correlated positively with CD90 (Tau=0.648, 
p=0.016; Tau=0.535, p=0.046, respectively), whereas T. forsythia and S. mitis correlated 
negatively with CD90 (Tau=-0.592, p=0.028; Tau=-0.535, p=0.046, respectively) (Table 2). 
The copy numbers of P. gingivalis correlated positively with the amounts of TGF-β and 
TNF-α in GCF of the GT-associated sites and also positively with the ratio of IL-17A:IL-17E 
mRNA (Tau=0.302, p=0.024; Tau=0.321, p=0.017; Tau=0.302, p=0.024, respectively; Table 
2), but P. gingivalis correlated negatively with TGF-β mRNA in GT (Tau=-0.368, p=0.007). 
Copy numbers of F. nucleatum and T. forsythia correlated positively with the ratio of IL-
17A:IL-17E mRNA in GT (Tau=0.296, p=0.027; Tau=0.307, p=0.022, respectively) and 
copy numbers of S. mitis correlated negatively with GCF IL-17A and with the ratio of IL-
17A:IL-17E mRNA in GT (Tau=-0.278, p=0.038; Tau=-0.278, p=0.038, respectively).  
Discussion  
The healing process of a wound occurs in at least four phases, coagulation, inflammation, 
proliferation and maturation.21 Granulation tissue (GT) has a large cell-infiltrate 
incorporating fibroblasts, macrophages and leukocytes, as well as randomly organised 
collagen fibres.22 From a clinical perspective, GT excision controls bleeding locally and thus 
contributes to a more efficient debridement of a periodontal osseous lesion while allowing 
space for the placement of graft materials.23-24 In both homeostasis and disease/injury, the 
perivascular regions in the periodontal ligament are enriched with stem/progenitor cells25 that 
can migrate to the wound site, attach to the denuded root surface, proliferate and mature to 
tissue-forming cells (osteoblasts, cementoblasts and fibroblasts) and also interact with other 
host cells by releasing regenerative signals, cytokines, growth factors, chemokines, etc.26 
There is growing evidence that GT-derived MSCs possess high regenerative potential and 
may be used as autologous transplants for subsequent periodontal reconstructive operations.7-
8,12 
In this study the GT was excised from residual periodontal pockets and the inflammatory 
infiltrate and presence of MSCs observed within this infected tissue reflected a chronic 
disease state, which remained unresolved. The primary interest of the current study was to 
address the question whether following cause-related periodontal treatment and inflammation 
control the surgical retention of GT has advantages in terms of promoting the healing 
processes. The GT biopsies and the disease-free connective tissue specimens contained MSC-
like cells that expressed CD105, CD146, CD106 (MSC-markers), as well as SSEA-4 
(embryonic marker). Cells at passage 2 expressed low levels of STRO-1 (<2%)27-28 -albeit 
also found by other studies-29 and of CD105 (49.2-61.3%).28-29 The tissues demonstrated a 
high inter-subject variability regarding the expression of these markers possibly reflecting 
heterogeneity of the cell population and respective variability in “stemness”.30 This could be 
attributed to several factors, i.e. culture conditions, disease conditions,31 or reflect the 
individual genetic background and not be necessarily linked to the presence or absence of 
inflammation.32 Within the limitations of the present study this marker expression variability 
was consistent between the diseased and healthy tissue specimens failing to support the 
notion that inflammation overtly affects the immunophenotype of stem cell-like populations 
isolated from GT. Gingival-MSCs have been shown to retain their proliferative ability after 
prolonged culture, to differentiate into multiple different cell lineages and release growth 
factors and cytokines that may facilitate repair of damaged tissues, while exhibiting unique 
immunomodulatory properties suggesting that they may play a potential role in tissue 
regenerative protocols.33-34 However, while the current study did not sought to determine 
whether inflammation altered the function and properties of the stem cell populations, there 
were no apparent differences in the morphology or immunophenotype between the GT-MSCs 
and G-MSCs. This finding partially concurs with previous data demonstrating that SC 
characteristics mainly in terms of morphology,proliferation and migration rate 
anddifferentiation potential remain largely unaffected by the inflammatory processes,7,32,34-37 
although different patterns in phenotypic and functional properties of cell subsets in health vs. 
disease are also seen.12,38-39 
Inflammatory cells in periodontal GT express pro-inflammatory cytokines that are related to 
bone resorption.40 A higher level of pro-inflammatory cytokine gene expression including 
TNF-α, IL-1β, IL-6 and IL-17A was found in GT than disease-free connective tissue, 
verifying presence of inflammation at periodontitis tissue sites.41-43 Despite greater 
expression of TNF-α, IL-1β, IL-6 and IL-17A genes in inflamed GT compared to disease-free 
samples, only TNF-α was significantly increased in GCF from diseased sites. Where the 
amount of TNF-α was high, the amount of IL-17E was low. In contrast to IL-1 or IL-6, it has 
been shown that TNF-α increases the expression of SC markers on dental pulp-derived 
MSCs, telomerase activity and the capacity for migration, proliferation, and differentiation.44 
These authors suggested that during the initial stage of wound healing, the inflammatory state 
may be of fundamental importance for both the attraction of MSCs and modulation of their 
“stemness”, while there is evidence to support that inflammatory conditions in the culture 
conditions mildly influence the MSC properties of stem/progenitor cells residing in 
periodontal connective tissues.28 The present study showed that GCF levels of IL-6 from 
diseased sites correlated with the expression of CD105. IL-6 is thought to maintain the 
proliferative and undifferentiated state of bone marrow-derived MSCs, which secrete copious 
amounts of IL-6, until they undergo osteogenic differentiation.45 IL-6 family cytokines have 
been implemented in the maintenance of embryonic and adult SCs,46-50 and in the increase of 
the capacity for in vitro wound healing.45 
There is contradicting evidence regarding IL-17A levels in GCF,51 saliva,51-52 and serum51 of 
periodontitis patients, but these investigations were performed on samples collected from 
periodontitis patients and matched healthy controls. Of note was that in the current study the 
matched samples originated from an apparently disease-free site and a single diseased site 
from the same individual, which during the healing process may show alterations in 
inflammatory regulators before overt clinical improvement occurs. A reduction of IL-17E in 
GCF at diseased sites supports previous observations from our group that IL-17E levels in 
biofluids were reduced in periodontitis51 and increased following successful periodontal 
therapy.53 Median levels of IL-17E-, IL-10- and TGF-β mRNAs tended to be higher in GT 
than disease-free tissue. Whether this is an early indication of changes within the GT to an 
anti-inflammatory and wound healing cytokine profile is unclear. Anti-inflammatory cytokine 
levels fall immediately after and remain depressed for several days following periodontal flap 
surgery, while levels of IL-1β and TNF-α are increased during the initial phases of wound 
healing.54 Anti-inflammatory cytokines have been shown to play a key role in the disease 
process,41-42 and along with the pro-inflammatory cytokines they are also implicated in the 
healing process.55 The inflammatory phase of a wound drives tissue healing as pro-
inflammatory cytokines activate the proliferative phase of wound healing for the restoration 
of the vascular network and GT formation,56 followed by tissue maturation and remodelling 
as inflammation is regulated by pro- and anti-inflammatory cytokines.5 MSC-like populations 
may assist in maintaining a balance of pro-inflammatory and anti-inflammatory processes 
favouring an anti-inflammatory reaction that drives wound healing. MSC-like cells derived 
from inflamed gingival tissues exhibit a similar phenotypic profile -in line with current 
findings-, in vitro differentiation capacity and in vivo developmental potential to MSC-like 
cells from healthy gingival tissues,34 although it has been shown that MSCs from inflamed 
tissues can exhibit altered stemness and immunomodulatory properties57-59 that may 
contribute to an imbalance in the local immune response and advancement of alveolar bone 
loss. On the premise that MSC-like cells promote tissue healing it is proposed that retaining 
the soft tissue wall of a periodontal defect during periodontal surgery and flap elevation 
would reduce soft tissue recession and promote periodontal wound healing and regrowth of 
lost tissues. There is evidence to support the clinical superiority of tissue-friendly and patient-
centred surgical techniques that minimise tissue trauma and retain the soft tissue 
architecture.60-62 The intrinsic healing potential of a wound occurs when ideal conditions are 
provided by the surgical approach,60-61 implying that substantial periodontal clinical 
improvements are attainable without the use of any regenerative graft materials. A clinical 
study in humans (Dept. of PDP&IB; ClinicalTrials.gov ID: NCT02449005) is underway and 
is expected to complement current findings regarding the premise of periodontal GT 
preservation during flap surgery. 
While there is no direct link between the microbes at the sulcus or periodontal pocket they 
probably contributed to the inflammatory response in the tissues, as there appears to be some 
correlation between certain microbes and cytokine expression, the cytokines, in turn could 
have had an impact on the SC population. In vitro experiments have shown that dental stem 
cells are less likely to interact directly with putative periodontal pathogens regarding 
adherence and internalization than differentiated cells in an anaerobic environment.63 Key 
periodontal pathogens were higher at the GT-sites compared to the disease-free sites as is in 
accord with the literature,64-65 whereas A. actinomycetemcomitans and S. mitis were similar at 
GT and disease-free sites. A. actinomycetemcomitans appears to be less prevalent in deep 
periodontal pockets66 and Streptococci are suggested to attenuate the pro-inflammatory 
response,67-69 while the literature suggests that MSCs may contribute to microbial defense.70 
F. nucleatum, T. denticola, and S. mitis correlated positively with CD90, whereas T. forsythia 
correlated negatively with this marker. Depressed expression of CD90 antigens associated 
with a diminished immunosuppressive activity of MSCs71. GCF IL-17E was correlated with 
the proportion of MSCs expressing CD106, an immunomodulatory molecule on the surface 
of MSCs.72 The associations between the microbes and local cytokines with the markers on 
MSCs detected in this investigation should be explored further. Although in comparisons of 
cells isolated from GT and disease-free tissue samples factors measured in this study had no 
detectable effect on the morphology and expression of CD markers on MSC-like cells. 
Further studies are required to document whether chronic inflammation alters the properties 
of MSCs isolated from periodontal GT and also to isolate and thoroughly characterise 
potential MSCs residing in periodontal GT before any therapeutic intervention is initiated 
Conclusion 
Periodontal lesions, albeit inflamed, retain healing potential as inferred by the presence of 
MSC-like cells with similar immunophenotypic characteristics to those found in clinically 
healthy periodontal tissues. The bacterial-driven inflammation and cytokine expression both 
in GCF of residual periodontal pockets and within the GT appears to correlate with SC 
markers of MSCs-like populations isolated from the GT; current data suggest there might be 
merits for healing in preserving sufficient GT in-situ during periodontal surgery, but the 
mode of healing and whether the process of healing would be repair or regeneration remains 
to be elucidated. 
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Figure legends  
Figure 1.   
Representative flow cytometry parameter diagrams showing percentage MSC surface 
epitopes in granulation tissue (GT-MSC) and in disease-free gingival connective tissue (G-
MSC) specimens of a single patient. Green line represents marker of interest and red line 
isotype control   
Figure 2.   
Summary data of flow cytometry, for stem cell markers expressed in granulation tissue (GT-
MSC) and in disease-free gingival connective tissue (G-MSC) specimens of ten patients.  
Large inter-subject variability is noted and no apparent dissimilarities between the GT-MSC 
and G-MSC cultures for any of the markers tested according to a permutation test with a 
Monte Carlo simulation: CD105, p=0.231; CD146, p=0.503; CD73, p=0.654; CD106, 
p=0.256; CD90, p=0.686; SSEA-4, p=0.506; CD271, p=0.179; CD34, p=0.563; CD45, 
p=0.128. 
Figure 3.   
Quantification of cytokine gene expression in granulation tissue (GT) and in disease-free 
tissue specimens (H) in the same individuals (n=15). Statistical significant differences are 
shown in asterisks (*p<0.05; **p<0.01; ***p<0.001). 
Figure 4.   
Cytokine levels in gingival crevicular fluid (GCF) associated with the granulation tissue sites 
(GT) and with the disease-free sites (H) in the same individuals (n=15). Significant 
differences are shown in asterisks (*p<0.05; **p<0.01; ***p<0.001). 
 Figure 5.   
Quantification of S. mitis and putative periodontal pathogens in subgingival plaque samples 
at sites associated with the granulation tissue biopsies (GT) and disease-free sites (H) in the 
same individuals (n=15). Significant differences are shown in asterisks (*p<0.05; **p<0.01; 
***p<0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tables and Figures 
 
Table 1.  Patient clinical data and demographic details (N=15) 
 
Gender Age No of Teeth  Full-mouth 
PPD (mm) 
Full-mouth 
CAL (mm) 
5-7mm sites 
(%) 
>7mm sites 
(%) 
7F / 8M 51.66 (7.33) 26.27 (3.06) 3.40 (0.75) 4.33 (1.16) 17.69 (12.22) 3.52 (5.21) 
Mean (SD) 
All participants were non-smokers and of Caucasian origin and had full-mouth plaque scores <20% 6-months 
following cause-related periodontal treatment. F: female; M: male; GT site: the periodontal defect from where 
granulation tissue and other samples (GCF, subgingival plaque) were collected; H-site: disease-free site from 
where a connective tissue specimen and other samples were collected.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.  Kendal Tau correlations between subgingival plaque micro-organisms, GCF and mRNA 
levels of cytokines associated with diseased sites in 15 patients and correlations with CD markers in 
10 patients  
  
IL-17A 
in GCF 
TGF-β 
in GCF 
TNF-α 
in GCF 
IL-17A:IL-17E 
mRNA in GT 
TGF-β 
mRNA in GT 
F.n. T.d. T.f. S.m. 
P.g. Tau= 
 
0.302 0.321 0.302 -0.368 
   
 
 
p= 
 
0.024 0.017 0.024 0.007 
   
 
F.n. Tau= -0.268 
  
0.296 
  
0.698 0.856  
 
p= 0.046* 
  
0.027 
  
<0.001 <0.001  
T.d. Tau= 
   
 
 
0.698 
 
0.72  
 
p= 
   
 
 
<0.001 
 
<0.001  
T.f. Tau= 
   
0.307 
 
0.856 0.720   
 
p= 
   
0.022 
 
<0.001 <0.001   
S.m. Tau= -0.278 
  
-0.278 
 
-0.841 -0.803 -0.744  
 
p=   0.038 
  
0.038 
 
<0.001 <0.001 <0.001  
CD90 Tau=      
0.648 0.535 -0.592 -0.535 
 p=      
0.016 0.046 0.028 0.046 
CD105 Tau=    -0.556  
    
 p=    0.037  
    
CD146 Tau= 0.511     
    
 p= 0.040     
    
Additional significant correlations: CD105 correlated with IL-17E mRNA in GT (Tau =0.667, p=0.012); CD105 
correlated with IL-6 in GCF (Tau = 0.556, p=0.025); CD106 correlated with IL-17E in GCF (Tau=0.600, p=0.016).  
*Significant correlations (Tau) p value is in bold. 
P.g. = P. gingivalis, F.n.=  F. nucleatum, T.d. = T. denticola, T.f.= T. forsythia, S.m.= S. mitis. 
Figure 1.  Representative flow cytometry parameter diagrams showing % expression of MSC surface 
epitopes in granulation tissue (GT-MSC) and in disease-free gingival connective tissue (G-MSC) 
specimens of a single patient. Green line represents marker of interest and red line isotype control   
 
 
 
 
Figure 2.  Summary data of flow cytometry for stem cell marker expression in granulation tissue (GT-
MSC) and in disease-free gingival connective tissue (G-MSC) specimens of ten patients 
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Large inter-subject variability is noted and no apparent dissimilarities between the GT-MSC and G-MSC 
cultures for any of the markers tested according to a permutation test with a Monte Carlo simulation: CD105, 
p=0.231; CD146, p=0.503; CD73, p=0.654; CD106, p=0.256; CD90, p=0.686; SSEA-4, p=0.506; CD271, p=0.179; 
CD34, p=0.563; CD45, p=0.128.   
Figure 3.  Quantification of cytokine gene expression in granulation tissue (NGT=15) and in disease-
free tissue specimens (NH=15); statistical significant differences are shown in asterisks (*p<0.05; 
**p<0.01; ***p<0.001) 
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Figure 4.  Cytokine levels in gingival crevicular fluid (GCF) associated with the granulation tissue sites 
(NGT=15) and with the disease-free sites (NH=15); significant differences are shown in asterisks 
(*p<0.05; **p<0.01; ***p<0.001) 
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Figure 5.  Quantification of S. mitis and putative periodontal pathogens in subgingival plaque 
samples at disease-free sites ((NH=15) and at sites associated with the granulation tissue biopsies 
(NGT=15); significant differences are shown in asterisks (*p<0.05; **p<0.01; ***p<0.001) 
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